Exsegen Genomics Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-12-2024
- Paid Up Capital ₹ 3.30 M
as on 13-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Exsegen Genomics Research
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.30 M, as per Ministry of Corporate Affairs (MCA) records.
Surya Madiraju, Amitava Ray, and Goutam Bhattacharyya serve as directors at the Company.
- CIN/LLPIN
U73100TG2020PTC139009
- Company No.
139009
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Exsegen Genomics Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amitava Ray  | Managing Director | 05-Feb-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surya Madiraju  | Director | 05-Feb-2020 | Current |
| Goutam Bhattacharyya | Additional Director | 19-Oct-2022 | Current |
Financial Performance of Exsegen Genomics Research.
Enhance accessibility to Exsegen Genomics Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Exsegen Genomics Research?
Unlock access to Exsegen Genomics Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exsegen Genomics Research?
Unlock and access historical data on people associated with Exsegen Genomics Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exsegen Genomics Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exsegen Genomics Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
